» Articles » PMID: 23714548

Understanding and Surviving the Transition to Value-based Oncology

Overview
Specialty Oncology
Date 2013 May 30
PMID 23714548
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

This paper and the three presentations it supports are drawn from the theme of the 2012 Cancer Center Business Summit (CCBS): "Transitioning to Value-Based Oncology: Strategies to Survive and Thrive." The CCBS is a forum on oncology business innovation, and the principal question the organizers address each year is "What are the creative, innovative, and best business models and practices that are being conceived or piloted today that may provide a responsible and sustainable platform for the delivery of cancer care tomorrow?" At this moment in health care-when so much is in flux and new business models and solutions abound-the oncology sector has a solemn responsibility: to forge the business models and relationships that will help to define a new cancer care value proposition and a sustainable health care system of tomorrow for the benefit of the patients it serves to get it "right."

Citing Articles

Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members.

Mullangi S, Ukert B, DeVries A, Debono D, Santos J, Fisch M J Clin Oncol. 2024; 43(2):133-142.

PMID: 39356984 PMC: 11708986. DOI: 10.1200/JCO.24.00502.


Payment Reform: Unprecedented and Evolving Impact on Gynecologic Oncology.

Apte S, Patel K Front Oncol. 2016; 6:84.

PMID: 27148476 PMC: 4831975. DOI: 10.3389/fonc.2016.00084.